Sun B, Lu Y, Liu W, Wang C, et al. Systems pharmacology reveals type I interferon and myeloid-like B cell reprogramming as candidate druggable axes in antiphospholipid syndrome. PLoS One 2026;21:e0349155.
PMID: 42647509